Core Insights - The National Healthcare Security Administration has released a guideline for pricing surgical and treatment auxiliary operations, focusing on advanced medical technologies such as 3D printing and robotic surgery [1][2] Group 1: Pricing Structure - The guideline establishes 37 pricing projects, 5 additional charges, and 1 expansion item, standardizing the pricing for robotic-assisted surgeries based on clinical value and participation levels [1] - A tiered pricing model is introduced for robotic surgeries, with higher fees for robots that are more involved and precise in surgical execution [1] - The guideline aims to ensure reasonable pricing standards across regions while enhancing the accessibility of robotic-assisted surgeries [1] Group 2: Remote Surgery - A new pricing project for "remote surgical assistance" has been established, facilitating the application of remote surgery in clinical settings [2] - This pricing structure allows medical institutions to charge for remote control of surgical instruments, promoting the expansion of quality medical resources across regions [2] - The implementation of remote surgery is expected to drive technological innovations in surgical robotics and navigation devices [2] Group 3: Consumables and Charges - The guideline clarifies the charging policies for reusable and disposable consumables, stating that they cannot be charged simultaneously [2] - Institutions using disposable consumables will sell them at zero markup, while those using reusable consumables will charge for auxiliary operation fees [2] - This regulation aims to curb unreasonable price increases and promote transparency in clinical charges [2] Group 4: Data and Future Applications - The guideline includes a "data reduction policy," where medical data storage and upload are part of the pricing structure [3] - Institutions must provide required data to avoid penalties, enabling the development of effective evaluation models for treatment efficacy [3] - This approach is expected to accelerate the development of new surgical techniques and expand applications in telemedicine and smart navigation [3] Investment Opportunities - The new policy is anticipated to resolve previous pricing ambiguities for surgical robots, emphasizing clinical value and participation levels [3] - Companies with technological advancements and product maturity, such as Tianzhihang-U, Jingfeng Medical-B, and others, are likely to benefit from the inclusion of robotic-assisted surgery in healthcare directories [3]

Core Viewpoint - The medical device sector is experiencing significant activity, with notable stock increases following the release of new pricing guidelines by the National Healthcare Security Administration, which includes 37 pricing projects for surgical and treatment auxiliary services [1] Group 1: Market Activity - The medical device sector saw a surge in stock prices, with Tianzhihang rising over 10% [1] - Other companies such as Sanyou Medical, Xishan Technology, Kangzhong Medical, and Tianyi Medical also experienced stock increases [1] Group 2: Regulatory Changes - On January 20, the National Healthcare Security Administration issued guidelines for pricing projects related to surgical and treatment auxiliary services [1] - The guidelines include 37 pricing projects, along with 5 additional charge items and 1 expansion item [1] - The new pricing projects cover important auxiliary technologies and products, including 3D printing, intraoperative guidance, surgical robotic arms, and remote surgery [1]

Core Viewpoint - The National Healthcare Security Administration of China is promoting the large-scale application of surgical robotic arms by establishing a new pricing project for "remote surgical assistance" to enhance the integration of advanced medical technologies into healthcare services [1][2]. Group 1: Pricing Guidelines and Projects - The National Healthcare Security Administration has accelerated the compilation and issuance of medical service pricing project guidelines, having released a total of 36 batches, with provinces averaging 30 batches implemented [1]. - The 37th batch of guidelines includes 37 pricing projects specifically for surgical and treatment assistance operations, along with 5 additional charge items and 1 expansion item, covering key technologies such as 3D printing, intraoperative guidance, and surgical robotic arms [1][2]. Group 2: Focus on Surgical Robots - The pricing guidelines focus on the participation level of surgical robots in operations and their clinical value in precision surgery, categorizing pricing into navigation, execution participation, and precision execution [2]. - A coefficient-based charging model is implemented, allowing surgical robots with higher participation, comprehensive functions, and precise execution to receive higher fee coefficients [2]. Group 3: Remote Surgery and Resource Allocation - The establishment of the "remote surgical assistance fee" pricing project aims to facilitate remote surgeries conducted by experts in resource-rich areas for patients in other regions, thereby reducing the burden of travel for patients seeking quality medical care [2]. - The National Healthcare Security Administration is closely monitoring innovations in the medical industry and has unified over a hundred prospective pricing projects related to new technologies and products, paving the way for gradual industrial upgrades and leading healthcare payment innovations [2].

Core Viewpoint - The National Healthcare Security Administration issued a draft guideline on December 5, 2025, establishing a unified pricing language for various medical services, which will significantly impact hospital operations, technology implementation speed, and corporate product strategies [2]. Group 1: Policy Impact - The draft guideline aims to standardize pricing for technologies such as 3D reconstruction, 3D printing, navigation, intraoperative imaging, energy platforms, surgical robots, and tele-surgery [2]. - The guideline is expected to enhance the understanding of the pricing structure among industry stakeholders, thereby reducing information asymmetry and improving overall policy interpretation capabilities [5]. Group 2: Industry Engagement - A closed-door discussion meeting is organized by Si Yu MedTech to facilitate high-level decision-makers and professionals in understanding the draft guideline and sharing experiences [3][4]. - The meeting will focus on the content framework and industry impact of the draft guideline, aiming to elevate the overall awareness and understanding among industry experts [5]. Group 3: Target Audience - The event is tailored for experienced professionals, including CEOs, product direction leaders, and market access professionals involved in healthcare policy and pricing strategies [6][8]. - The format encourages interaction and knowledge sharing rather than formal policy training, fostering a collaborative environment for industry insights [8].